| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9377717 | Biological Psychiatry | 2005 | 5 Pages |
Abstract
Volumetric increase of cerebral cortical gray occurred early in the course of treatment with the SGAs ziprasidone and risperidone, but not with the FGA haloperidol. Such cortical gray expansion may be relevant to the reported enhanced neurocognition and quality of life associated with SGA treatment.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
David L. Garver, Jennifer A. Holcomb, James D. Christensen,